OUHSC Research News – Monday, March 27, 2023
Workshops and Seminars
Lunch & Learn: Patents 101: Innovation Pathway (iPath)
Office of Innovation and Corporate Partnerships
Date: Wednesday, March 29, 2023; 12:00 p.m. (CDT)
Topics
- Opportunity for OU researchers and innovators to explore the value and marketability of their business idea
- Multi-step journey to better understand where your idea fits in the marketplace
- How to advance your idea
- Help to articulate the value of your business proposition
- Help to view your discovery through a market lens
Space is limited, so reserve your spot now. We can't wait to see you
Register for the event: https://oklahoma.zoom.us/meeting/register/tJIkce6spzIrHtDTX4ygBAma0VpHY5dcZzIW
Website: ou.edu/oicp
For questions or accommodations, contact oicp@ou.edu
SPINPLUS Funding Database Webinar
Date: Tuesday, April 4, 2023 – 12:00 -1:00 pm Central Time
Location: Online
With: Bill DeCocco, InfoEd
Description: SPINPlus is a funding search database available to all faculty, staff, and students. The system provides both text and keyword search modes. Attendees of the SPINPlus session will learn how to create an account, search for funding opportunities and narrow results by setting filters. We will also explore saving searches along with activating SMARTS e-mail notifications. This webinar will cover basic login, searches, and notifications from the system.
Registration: https://ousurvey.qualtrics.com/jfe/form/SV_9RlqAQk3rdL3o5U
Save the Date! Spring for Research Days 2023
April 4 – April 5
Save the date for OU-Tulsa’s annual Spring for Research Days (formerly Research Week), April 4 – April 5, 2023.
Save space on your calendar for these great opportunities to learn more about research conducted by OU-Tulsa students, residents, faculty, and staff.
Lightning Round Session
11am to 12pm |Schusterman Library Gallery
Research Forum
2pm to 4pm | Founder’s Hall, OU-Tulsa Learning Center
Call for Presentations - 29th Annual Zarrow Mental Health Symposium
Description: Mental Health Association Oklahoma seeks presentation proposals from presenters around the globe interested in sharing information about treatment modalities, programs, research findings, policies and practices that are informed by science and use creative and innovative approaches to mental health. Presentations utilizing technology, innovative collaborations, new treatment and program models, and emerging knowledge and methodologies are encouraged.
Application must be submitted via the online portal found at zarrowsymposium.org, no later than Friday, April 7, 2023 to be eligible for consideration.
Questions: Please contact JoBeth Hamon at 405.898.8704 or jhamon@mhaok.org.
Additional information: Please refer to the attached flyer.
2023 Oklahoma Geroscience Symposium (Save the date)
Date: Monday, April 3, 2023
Time: 8:25 - 5:00 PM CST with Faculty/Trainee Mixer to Follow at 5:00 PM. Poster session 12:15 - 2:00 together with lunch.
Location: In-person
Nicholson Tower, Floor 5, 1000 NE 13th St. Oklahoma City, OK 73104
Description: "Cell non-autonomous mechanisms of aging: Crosstalk between the periphery and the brain"
Sponsored by the Oklahoma Nathan Shock Center on Aging
Registration is free
Questions? If you have any questions regarding the symposium, please email Laura Otalora, Laura-Otalora@OUHSC.edu
Registration: https://oklahomanathanshockcenteronaging.org/symposium-registration/
Abstract Submissions: https://oklahomanathanshockcenteronaging.org/abstract-submissions/
2023 Oklahoma Gero-Oncology Symposium
Date: Tuesday, April 4, 2023
Time: 8:15 - 5:25 PM CST | Reception to Follow
Location: In-person & via Zoom
Nicholson Tower, Floor 5, 1000 NE 13th St. Oklahoma City, OK 73104
Description: Learn about the developments and progress happening in geriatric oncology regarding sarcopenia in aging and cancer cachexia from leading experts across the country. This symposium will feature a roundtable discussion with speakers from NCI and NIA as well as a poster session.
Full agenda coming soon.
Sponsored by OU Health Stephenson Cancer Center and the Oklahoma Nathan Shock Center on Aging
Questions? If you have any questions regarding the symposium, please email Emily Hulseberg at emily-hulseberg@ouhsc.edu.
Registration: https://oklahomanathanshockcenteronaging.org/symposium-registration/
Abstract Submissions: https://oklahomanathanshockcenteronaging.org/abstract-submissions/
OCRID 10th Annual Research Symposium
Date: Tuesday, April 11, 2023, 8:00 AM – 6:00 PM CDT
Location: McKnight Center for the Performing Arts, 705 West University Avenue Stillwater, OK 74074
Description: The Oklahoma Center for Respiratory and Infectious Diseases is a multi-institutional center with investigators coming from Oklahoma State University, University of Oklahoma, and the Oklahoma Medical Research Foundation.
The OCRID Annual Research Symposium provides an opportunity for researchers and students in the fields of respiratory and infectious diseases to gather, network, and learn together from a group of outstanding local and national leaders in their fields. Research disciplines include molecular biology, pathology, animal models, disease pathogenesis, therapeutics, molecular mechanisms, and bioengineering.
The one-day symposium features keynote speakers, showcases the progress of OCRID investigators’ projects and the update from OCRID core facilities, and hosts a poster competition with cash prizes. A catered breakfast, refreshment breaks, and lunch will be provided throughout the day.
Registration and additional information: Please refer to the attached flyers.
OUHSC Funding Opportunities
Request for applications: Genetic CRISPR Screening Pilot Award Program from the Oklahoma Nathan Shock Center on Aging and Oklahoma Center for Therapeutic Sciences
The Oklahoma Nathan Shock Center on Aging (NSC) and the Oklahoma Center for Therapeutic Sciences (CTS) are soliciting proposals for Pilot Awards in target and pathway discovery in cell-based models of aging and age-associated disease using high throughput screening and arrayed sgRNA CRISPR technologies. Please see the attached RFA for more details.
2023 Innovations in Aging Day
Please join the Oklahoma Dementia Care Network, the OU College of Medicine Section of Geriatrics and Palliative Medicine, and the OU Hudson College of Public Health for the 2023 Innovations in Aging Day, Tuesday April 18, 2023, 12:15pm to 4pm (virtually), held in conjunction with Careers in Aging Week. Don’t forget about the Abstract Competition for best innovations in clinical care/quality improvement, research, health professions education, or community-based interventions related to aging. Deadline to submit is March 31, 2023. There will be a cash prize ($250) for the 3 best abstracts, plus an invitation to present at the conference! Click the link below to enter the competition.
Registration link: https://www.ouhealth.com/events-calendar/event-details/?event=30523
Abstract Competition link: https://ousurvey.qualtrics.com/jfe/form/SV_8ujsmTPhUciaMjc
The Center of Biomedical Research Excellence (COBRE) Pilot Project RFA
Description: The NIH/NIGMS-funded Oklahoma Center of Biomedical Research Excellence (COBRE) in Microbial Pathogenesis and Immunity invites proposals for pilot project awards. Pilot projects will enable investigators to generate data to support new lines of investigation funded by national level awards. The pilot project may constitute the entire basis for a new national level (NIH or NSF) funding proposal, or may extend the scope or strengthen a planned application. Pilot projects must be of high significance and enhance or generate funding proposals that will exert a high impact on the applicant’s field of research.
Eligibility Requirements: The project Principal Investigator (PI) must be a consecutive term, tenure-track, or tenured faculty member at an Institution in the State of Oklahoma. First preference will be given to junior investigators within 5 years of their initial appointment and who currently hold NIH New Investigator status. Established investigators (NIH Established Investigator, Associate Professor, and Professor) and those beyond the initial 5 year period are eligible, but the applicant must clearly demonstrate how the pilot project will add a new element or direction to the PI’s research program. The PI may not concurrently hold other COBRE or INBRE support as a full project or pilot project PI. This includes other COBRE programs in Oklahoma. Past recipients of pilot project awards will be considered for a second award contingent on priority and having fulfilled all requirements of the previous award.
Awards: The award will be $50,000 per annum in direct costs. Institutional F&A costs will also be provided for applicants at institutions outside of OUHSC. Projects may be funded for up to 2 years contingent upon fulfilling award requirements and satisfactory progress. Sub-contracts are not allowable.
Application Deadline: 5pm, March 31, 2023
Application Format and additional information: Please see the attached flyer.
Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications
Cycle I PHF Bridge Grant Program Deadline: April 3, 2023
The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques.
IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.
American Cancer Society Institutional Research Grant (ACS IRG) – 2023 Spring Cycle
Description: The ACS-IRG is a unique source of funding entrusted to Stephenson Cancer Center (SCC) that provides seed money for early-stage faculty interested in cancer-related research - the ACS has provided SCC with supplemental monies that allow support up to two awards. ACS-IRG funds will provide $50,000 to new/early stage faculty with Cancer Research pilot projects.
Eligibility Criteria:
-
ASSISTANT PROFESSOR or equivalent level position that holds a Tenure- or Research-track appointment on OUHSC, OU-Norman or OU-Tulsa campus and within SIX years of first independent academic appointment.
-
Without CURRENT grant support from national funding agencies (e.g. NIH, DOD, NSF, ACS).
Deadline: Wednesday, April 5th, 2023, Due by 5:00 PM (CST)
Application, Guidelines and more information can be found: Application, Forms & Guidelines | SCC Website
Questions: please contact the SCC Office of Cancer Research at CancerResearch@ouhsc.edu
OUHSC College of Medicine Research Fund
Description: Proposals are being accepted from full time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund. COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early stage investigators in the College of Medicine. The guidelines are included with this notice. Applications will be reviewed by a scientific panel whose composition will be determined on the types of applications received. Awards generally fall within the $20,000 to $45,000 range ($45,000 maximum request).
All applications must be routed through the Office of Research Administration and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official.
Below are New Guidelines for routing applications and for formatting applications for the COLLEGE OF MEDICINE ALUMNI ASSOCIATION (COMAA) research program:
Submission of application for review
- At least five days prior to submission of the grant application, you must submit an electronic routing form using SOONERTRACKGRANTS (http://soonertrack.ouhsc.edu/SoonerTrackGrants.aspx).
- This program follows a Just-In-Time application process; therefore, approval of Institutional Review Board, Institutional Animal Care and Use Committee, Radiation Safety Committee and Institutional Biosafety Committee, where applicable, are not needed unless the application is being recommended for COMAA funding. Applicants should only submit this information when it is requested by the Office of the Vice President for Research. All protocols must be approved by the relevant review committees before funds are awarded.
- The completed COMAA application must be submitted via e-mail to COMAA-Research@ouhsc.edu (cc marybeth-humphrey@ouhsc.edu) no later than 5 pm, Wednesday, April 5, 2023. The application must be a single file in a pdf format and be titled “COMAA [PI Name]”. Only applications that conform to the COMAA Grant Guidelines will be forwarded to the Grant Review Panel for consideration.
- Questions about the application submission process should be addressed to Associate Dean for Research for the College of Medicine, Dr. Mary Beth Humphrey (Marybeth-humphrey@ouhsc.edu).
Please submit an electronic copy of the application along with a copy of the Completed and Approved Soonertrack Routing Form (Soonertrackgrants.ouhsc.edu). A screenshot of the completed online PDF form will be accepted). Application must be reviewed and approved for submission by the Office of Research Administration (ORA) prior to the final application being submitted.
The start date for funded COMAA proposals will be July 1, 2023.
Applications Due: Applications should be sent electronically to COMAA-Research@ouhsc.edu by 5 pm on Wednesday, April 5, 2023.
Guidelines for the Submission of Proposals: Please refer to the attached application guide.
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).
- Ipsen, a global biopharmaceutical company, is seeking novel and innovative leads to treat rare diseases and rare neuroscience disease indications. A range of therapeutic areas, targets, and mechanisms-of-action and classes of molecules are of interest, with a specific focus on small molecule, peptide, biologics, nucleic acids, RNA therapies and antibody conjugates. Out of scope are gene therapy, cell therapy, vaccines, generics and natural products. Submission entails a 1-pg non-confidential proposal form, including workplan and budgetary requirements. (deadline 4/12).
- Astellas Pharma is seeking research related to direct reprogramming to achieve transdifferentiation of cells to another functional type in order to discover therapeutic interventions for degenerative diseases.. Direct reprogramming of cells to cell types related to CNS, Lung, Heart, Kidney, Liver, Gut, Skin and Eye are of particular interest; all methods of in vivo reprogramming considered. Cell therapy, cell transplantation, biomaterial-based therapy and CRISPR/Cas systems are out of scope. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 4/26).
- Cumulus Oncology is looking to engage with academics who have highly tumor-restricted antigens or moloclonal or multvalent antibodies that target them with potential for therapeutic activity in cancer. Embryonic cell targets are priority but others considered if sufficient tumor-specific activity to minimize off-target effects. Solid tumors are highest interest but all cancers are within scope. Out of scope: drug repurposing, small molecule, small antibodies, ADC, immunotoxins, radioimmunotherapy, gene therapy and call based therapeutics. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 4/26).
- A global pharmaceutical company is looking to identify novel methods for discovery or design of orally bioavailable peptides and/or peptides that can access intracellular targets through passive permeation, endocytosis or via transporters. Novel in vitro assays for prediction of bioavailability/intracellular targeting with proven translation to in vivo models are also of interest. Out of scope: use of well-known cell-penetrating peptides (unless significant innovation is demonstrated) and drug delivery systems/formulation strategies. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 4/26)
Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit Description: Grant proposals are being accepted for the 2023 Spring cycle from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $100,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Grant template and Submission Checklist provided with this notice. Investigators should request the budget template from the Protocol Support Unit.
Deadline: April 3, 2023 at 5 pm CST
Link to the full announcement or a flier: Please refer to the attached flyer for additional funding criteria and details
NIH Notices
NIH Funding Opportunities
- Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
(PAR-22-265)
Application Receipt Date(s): Multiple dates, see announcement.
- NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
(PAR-23-113)
Application Receipt Date(s): May 25, 2024
- Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
(PAR-23-138)
Application Receipt Date(s): June 02, 2025
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
(PAR-23-139)
Application Receipt Date(s): May 30, 2025
- NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
(PAR-23-269)
Application Receipt Date(s): Multiple dates, see announcement.
- Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
(RFA-CA-23-028)
Application Receipt Date(s): June 13, 2025
- Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed)
(RFA-ES-23-008)
Application Receipt Date(s): July 07, 2023
- Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
(RFA-MH-23-140)
Application Receipt Date(s): June 21, 2023
- Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed)
(RFA-RM-23-008)
Application Receipt Date(s): May 15, 2023
- Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed)
(RFA-RM-23-009)
Application Receipt Date(s): May 15, 2023
- Limited Competition: Molecular Transducers of Physical Activity Clinical Centers (U01 Clinical Trial Required)
(RFA-RM-23-010)
Application Receipt Date(s): May 15, 2023
- Limited Competition: Molecular Transducers of Physical Activity Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-RM-23-011)
Application Receipt Date(s): May 15, 2023
Other Funding Opportunities
The American Heart Association Clinical Fellow Research Education Program
Description: This program will provide funding for cardiology and select neurology fellows in accredited fellowship programs to attend an AHA scientific meeting (Scientific Sessions or the International Stroke Conference, respectively) and gain other training and experience integral to development of research acumen. This includes ACGME-accredited cardiology subspecialty programs and ACGME- or UCNS-accredited vascular/neuroendovascular/geriatric neurology subspecialty programs. Institutions are strongly encouraged to use funding for fellows from racial and ethnic groups underrepresented in medicine and science. Awards will be three years in duration and will support up to five fellows annually.
Application Deadline: April 13, 2023
Link to Full Announcement: https://professional.heart.org/en/research-programs/aha-funding-opportunities/a2c-clinical-fellow-research-education-program
The Lung Cancer Research Foundation (LCRF) – Daiichi Sankyo – AstraZeneca Research Grant on Antibody Drug Conjugates
Description: LCRF is pleased to announce a collaboration with Daiichi Sankyo and AstraZeneca to fund up to three research grants focused on antibody drug conjugates (ADCs) to improve outcomes for people with lung cancer. This competitive funding mechanism will provide up to $270,000 in funding over a two-year period.
The LCRF - Daiichi Sankyo - AstraZeneca Research Grant on Antibody Drug Conjugates will develop further understanding of the mechanism of action and biomarkers for TROP2 directed ADCs in lung cancer and HER2 directed ADCs in HER2 mutant NSCLC and primary and acquired resistance to TROP2 directed and HER2 directed ADCs.
Application Deadline: May 31, 2023
Link to Full Announcement: Complete details including eligibility criteria and application instructions may be found on the LCRF website.
Chan Zuckerberg Initiative (CZI) Request for Applications: Ben Barres Early Career Acceleration Award RFA
Description: The Chan Zuckerberg Initiative invites applications for the second cycle of the Ben Barres Early Career Acceleration Awards. This is an investigator award for early career academic investigators, especially those who are new to the field of neurodegeneration. Awards are $1.2M in total costs over 4 years. Early career investigators will benefit from mentored support and resources of the CZI Neurodegeneration Challenge Network.
Letter of Intent (LOI) Deadline: April 20, 2023
Link to Full Announcement: https://chanzuckerberg.com/rfa/ben-barres-early-career-acceleration-awards/
Robert A. Winn Career Development Award (Winn CDA)
Description: The goal of the Robert A. Winn Career Development Award (Winn CDA) is to increase the diversity of patients enrolled in clinical trials, and ultimately to enhance the development of therapeutics for all populations. The program collaborates with communities to facilitate an approach to clinical and translational research that is community-informed, designed, and conducted. It provides emerging investigators the sponsorship, support, and tools they need to conduct clinical trials that will yield new treatments effective in all populations.
Application Deadline: May 12, 2023
Link to Full Announcement: https://diversityinclinicaltrials.org/application-information . Please see the attached flyers.
HRSA Nurse Education, Practice, Quality and Retention (NEPQR)-Pathway to Registered Nurse Program (PRNP) (HRSA-23-016)
Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO). The Nurse Education, Practice, Quality and Retention (NEPQR) - Pathway to Registered Nurse Program (PRNP) aims to create a pathway from academic training to clinical practice through the creation and implementation of Licensed Practical Nurse/Licensed Vocational Nurse (LPN/LVN) to Registered Nurse (RN) Bridge Programs and employment of Clinical Nurse Faculty.
HRSA will award approximately $8.9 million to up to 8 cooperative agreements over a period of four years.
Application Deadline: April 27, 2023
Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-016?UTM_campaign=NOFO
DoD Ovarian Cancer Research Program (OCRP)
- Investigator-Initiated Research Award (IIRA)
- Ovarian Cancer Academy Award - Early-Career Investigator (OCA)
- Pilot Award (PA)
Pre-Application: April 17, 2023
Application: July 21, 2023
- Clinical Translational Research Award
- Clinical Trial Award
- Ovarian Cancer Clinical Trial Academy - Leadership Award
Pre-Application: May 26, 2023
Application: July 21, 2023
Link to Full Announcement: https://cdmrp.health.mil/funding/ocrp
The Leona M. and Harry B. Helmsley Charitable Trust- Request for Applications to advance collaborative research in T1D prevention
Description: This RFP supported in collaboration with JDRF Australia, seeks collaborative projects to help answer unknowns about T1D biological mechanisms, with studies on its samples and data collected from pregnancy through childhood from children with an immediate family member with T1D.
LOI Deadline: April 7, 2023
Link to Full Announcement: https://jdrf.org.au/for-researchers/type-1-diabetes-prevention-rfa/
HRSA Advanced Nursing Education Workforce (ANEW) Program (HRSA-23-014)
Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO). The Advanced Nursing Education Workforce (ANEW) Program aims to increase the number of primary care nurse practitioners, clinical nurse specialists, and certified nurse midwives trained and prepared to provide primary care services, mental health and substance use disorder care, and maternal health care. The grants will support the training and graduation of advanced practice registered nursing (APRN) students and trainees in these disciplines.
Application Deadline: April 7, 2023
Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-014?UTM_campaign=Funding+Announcement+-+Advanced+Nursing+Education+Workforce
HRSA Advanced Nursing Education Nurse Practitioner Residency and Fellowship (ANE-NPRF) Program (HRSA-23-009)
Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO) for the Advanced Nursing Education Nurse Practitioner Residency and Fellowship (ANE-NPRF) Program, which aims to prepare new Advanced Practice Registered Nurses (APRNs) to effectively provide primary care by supporting transition to practice through the expansion and/or enhancement of existing Nurse Practitioner (NP) residency programs. The program also focuses on the integration of behavioral health and maternal health into primary care by training new primary care providers, behavioral health providers, and certified nurse midwives in community-based settings.
HRSA will award approximately $30 million to up to 43 grantees over a period of four years.
Application Deadline: April 11, 2023
Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-009?UTM_campaign=NOFO+Announcement+-+ANE+NPRF+Program
DoD Amyotrophic Lateral Sclerosis Research Program (ALSRP)
Pre-Application: 4-13-2023
Application: 7-13-2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495104
DoD Epilepsy Research Program (ERP)
Pre-Application (Letter of Intent): 5-19-2023
Application: 6-23-2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495101
DoD Peer Reviewed Medical Research Program (PRMRP)
Pre-Application (Letter of Intent): 4-12-2023
Application: 7-19-2023
Pre-Application (Letter of Intent): 4-12-2023
Application: 7-19-2023
Pre-Application (Letter of Intent): 4-19-2023
Application: 5-31-2023
Pre-Application (Letter of Intent): 4-19-2023
Application: 5-31-2023
Pre-Application (Letter of Intent): 4-19-2023
Application: 5-31-2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495103
The International Center for Responsible Gaming - REQUEST FOR APPLICATIONS ON RESEARCH ON PRE-COMMITMENT AS A PREVENTION MEASURE TO REDUCE GAMBLING-RELATED HARMS
Description: The International Center for Responsible Gaming (ICRG) invites investigators to apply for a two-year Large Grant to study the effectiveness of “pre-commitment,” a prevention strategy that encourages gamblers to set limits on money and time spent gambling. Applicants may request up to a total of $75,000 per year for up to two years plus 15 percent in Facilities & Administration costs. Total amount that may be requested is $172,500.
Application Deadline: May 15, 2023
Link to Full Announcement: https://www.icrg.org/information/apply-for-icrg-funding